Search by Drug Name or NDC
NDC 17433-9877-06 ENEMEEZ Plus 20; 283 mg/5mL; mg/5mL Details
ENEMEEZ Plus 20; 283 mg/5mL; mg/5mL
ENEMEEZ Plus is a RECTAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Enemeez LLC DBA Summit Pharmaceuticals. The primary component is BENZOCAINE; DOCUSATE SODIUM.
Product Information
NDC | 17433-9877 |
---|---|
Product ID | 17433-9877_0555d5ed-ff59-3e3c-e063-6294a90a9949 |
Associated GPIs | 46500010055120 |
GCN Sequence Number | 068186 |
GCN Sequence Number Description | docusate sodium/benzocaine ENEMA 283-20MG/5 RECTAL |
HIC3 | Q3S |
HIC3 Description | LAXATIVES, LOCAL/RECTAL |
GCN | 30915 |
HICL Sequence Number | 001321 |
HICL Sequence Number Description | DOCUSATE SODIUM/BENZOCAINE |
Brand/Generic | Brand |
Proprietary Name | ENEMEEZ Plus |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | docusate sodium and benzocaine |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | RECTAL |
Active Ingredient Strength | 20; 283 |
Active Ingredient Units | mg/5mL; mg/5mL |
Substance Name | BENZOCAINE; DOCUSATE SODIUM |
Labeler Name | Enemeez LLC DBA Summit Pharmaceuticals |
Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Listing Certified Through | 2024-12-31 |
Package
NDC 17433-9877-06 (17433987706)
NDC Package Code | 17433-9877-6 |
---|---|
Billing NDC | 17433987706 |
Package | 35 TUBE in 1 CONTAINER (17433-9877-6) / 5 mL in 1 TUBE (17433-9877-0) |
Marketing Start Date | 2021-10-08 |
NDC Exclude Flag | N |
Pricing Information | N/A |